These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Predictors for neoplastic progression in patients with Barrett's Esophagus: a prospective cohort study. Sikkema M, Looman CW, Steyerberg EW, Kerkhof M, Kastelein F, van Dekken H, van Vuuren AJ, Bode WA, van der Valk H, Ouwendijk RJ, Giard R, Lesterhuis W, Heinhuis R, Klinkenberg EC, Meijer GA, ter Borg F, Arends JW, Kolkman JJ, van Baarlen J, de Vries RA, Mulder AH, van Tilburg AJ, Offerhaus GJ, ten Kate FJ, Kusters JG, Kuipers EJ, Siersema PD. Am J Gastroenterol; 2011 Jul; 106(7):1231-8. PubMed ID: 21577245 [Abstract] [Full Text] [Related]
5. Barrett's esophagus and adenocarcinoma risk: the experience of the North-Eastern Italian Registry (EBRA). Rugge M, Zaninotto G, Parente P, Zanatta L, Cavallin F, Germanà B, Macrì E, Galliani E, Iuzzolino P, Ferrara F, Marin R, Nisi E, Iaderosa G, Deboni M, Bellumat A, Valiante F, Florea G, Della Libera D, Benini M, Bortesi L, Meggio A, Zorzi MG, Depretis G, Miori G, Morelli L, Cataudella G, d'Amore ES, Franceschetti I, Bozzola L, Paternello E, Antonini C, Di Mario F, Dal Bò N, Furlanetto A, Norberto L, Polese L, Iommarini S, Farinati F, Battaglia G, Diamantis G, Realdon S, Guido E, Mastropaolo G, Canova D, Guerini A, Franceschi M, Zirillo M. Ann Surg; 2012 Nov; 256(5):788-94; discussion 794-5. PubMed ID: 23095623 [Abstract] [Full Text] [Related]
7. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma. Weston AP, Badr AS, Hassanein RS. Am J Gastroenterol; 1999 Dec; 94(12):3413-9. PubMed ID: 10606296 [Abstract] [Full Text] [Related]
8. Dysplasia and risk of further neoplastic progression in a regional Veterans Administration Barrett's cohort. Dulai GS, Shekelle PG, Jensen DM, Spiegel BM, Chen J, Oh D, Kahn KL. Am J Gastroenterol; 2005 Apr; 100(4):775-83. PubMed ID: 15784018 [Abstract] [Full Text] [Related]
15. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management. Chennat J, Ross AS, Konda VJ, Lin S, Noffsinger A, Hart J, Waxman I. Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948 [Abstract] [Full Text] [Related]
16. Incidence of adenocarcinoma among patients with Barrett's esophagus. Hvid-Jensen F, Pedersen L, Drewes AM, Sørensen HT, Funch-Jensen P. N Engl J Med; 2011 Oct 13; 365(15):1375-83. PubMed ID: 21995385 [Abstract] [Full Text] [Related]
18. The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for disease progression. Skacel M, Petras RE, Gramlich TL, Sigel JE, Richter JE, Goldblum JR. Am J Gastroenterol; 2000 Dec 13; 95(12):3383-7. PubMed ID: 11151865 [Abstract] [Full Text] [Related]
19. Surveillance of Barrett's esophagus and mortality from esophageal adenocarcinoma: a population-based cohort study. Verbeek RE, Leenders M, Ten Kate FJ, van Hillegersberg R, Vleggaar FP, van Baal JW, van Oijen MG, Siersema PD. Am J Gastroenterol; 2014 Aug 13; 109(8):1215-22. PubMed ID: 24980881 [Abstract] [Full Text] [Related]
20. Risk stratification of patients with barrett's esophagus and low-grade dysplasia or indefinite for dysplasia. Thota PN, Lee HJ, Goldblum JR, Liu X, Sanaka MR, Gohel T, Kanadiya M, Lopez R. Clin Gastroenterol Hepatol; 2015 Mar 13; 13(3):459-465.e1. PubMed ID: 25102445 [Abstract] [Full Text] [Related] Page: [Next] [New Search]